FDA 483 - ActiGraph, LLC - July 30, 2015

Actigraph, LLC in Pensacola, FL, a medical device specification developer, was cited with four observations during an FDA inspection. The inspection revealed deficiencies in complaint handling, design validation, corrective and preventive action documentation, and quality audit procedures. These issues indicate a need for improved quality system controls to ensure compliance.